262 related articles for article (PubMed ID: 36568076)
1. Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.
Chi H; Peng G; Yang J; Zhang J; Song G; Xie X; Strohmer DF; Lai G; Zhao S; Wang R; Yang F; Tian G
Front Endocrinol (Lausanne); 2022; 13():1056310. PubMed ID: 36568076
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
3. Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy.
Li Y; Cai H; Yang J; Xie X; Pei S; Wu Y; Zhang J; Song G; Zhang J; Zhang Q; Chi H; Yang G
Front Pharmacol; 2023; 14():1264345. PubMed ID: 37822877
[No Abstract] [Full Text] [Related]
4. Machine learning to establish three sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with gastric cancer.
Yan J; Yu X; Li Q; Miao M; Shao Y
BMC Genomics; 2024 Mar; 25(1):319. PubMed ID: 38549047
[TBL] [Abstract][Full Text] [Related]
5. Programmed Cell Death-Related Gene Signature Associated with Prognosis and Immune Infiltration and the Roles of HMOX1 in the Proliferation and Apoptosis were Investigated in Uveal Melanoma.
Zhao Y; Wang L; Li X; Jiang J; Ma Y; Guo S; Zhou J; Li Y
Genes Genomics; 2024 May; ():. PubMed ID: 38767825
[TBL] [Abstract][Full Text] [Related]
6. EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients.
Lv Y; He L; Jin M; Sun W; Tan G; Liu Z
J Oncol; 2022; 2022():5436988. PubMed ID: 35990996
[TBL] [Abstract][Full Text] [Related]
7. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract][Full Text] [Related]
8. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
Wan Q; Ren X; Tang J; Ma K; Deng YP
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
[TBL] [Abstract][Full Text] [Related]
9. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
Zhan Z; Lin K; Wang T
BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract][Full Text] [Related]
11. Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma.
Xie J; Chen L; Cao Y; Ma C; Zhao W; Li J; Yao W; Hu Y; Wang M; Shi J
Aging (Albany NY); 2023 Mar; 15(6):2082-2096. PubMed ID: 36920166
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.
Chi H; Peng G; Yang J; Zhang J; Song G; Xie X; Strohmer DF; Lai G; Zhao S; Wang R; Yang F; Tian G
Front Endocrinol (Lausanne); 2024; 15():1421538. PubMed ID: 38784067
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan metabolism-related gene expression patterns: unveiling prognostic insights and immune landscapes in uveal melanoma.
Wang J; Zhao T; Li B; Wei W
Aging (Albany NY); 2023 Oct; 15(20):11201-11216. PubMed ID: 37844995
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy.
Li X; Kang J; Yue J; Xu D; Liao C; Zhang H; Zhao J; Liu Q; Jiao J; Wang L; Li G
Aging (Albany NY); 2023 May; 15(9):3442-3464. PubMed ID: 37142279
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
16. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.
Xie J; Chen L; Tang Q; Wei W; Cao Y; Wu C; Hang J; Zhang K; Shi J; Wang M
Front Immunol; 2022; 13():847624. PubMed ID: 35242144
[TBL] [Abstract][Full Text] [Related]
17. BAG2 Is a Novel Prognostic Biomarker and Promising Immunotherapy Target in Uveal Melanoma.
Li C; Shi H
Crit Rev Eukaryot Gene Expr; 2023; 33(6):55-71. PubMed ID: 37522545
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
Wang J; Liu M; Sun J; Zhang Z
J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
[TBL] [Abstract][Full Text] [Related]
19. A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma.
Huang W; Yang F; Zhang Y; Fang Q; Lai Y; Lan Y
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511120
[TBL] [Abstract][Full Text] [Related]
20. Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.
Zhang X; Zhuge J; Liu J; Xia Z; Wang H; Gao Q; Jiang H; Qu Y; Fan L; Ma J; Tan C; Luo W; Luo Y
Front Immunol; 2023; 14():1153423. PubMed ID: 37006285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
